News
Academy
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Latest Executive Roundtables
  • Asembia 2025
  • Sales Effectiveness
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe

News

Webcast

Webcasts

September 30, 2024

Uncovering the Missing Link in AI-Enhanced Field Rep Support

Author(s):

ACTO

Webinar Date/Time: Thu, Oct 17, 2024 11:00 AM EDT

Field reps need reliable, real-time assistance during HCP interactions. Without it, they risk using noncompliant information. Discover how AI knowledge assistance can provide compliant, intelligent support to strengthen HCP relationships.

Register Free: https://www.pharmexec.com/pe_w/missing-link

Event Overview:

AI has transformed commercial teams, boosting efficiency in marketing, HCP targeting, and workflow automation.

Yet, a critical gap exists: field reps need reliable, real-time assistance in preparation for and during HCP interactions. Without it, they risk using non-compliant AI tools or improvising responses to key questions.

In this webinar, discover how AI knowledge assistants, built for Life Sciences, can provide compliant and accurate answers to support reps and strengthen HCP relationships.


Key Learning Objectives

  • Understand the gap that AI fills in the field
  • Learn how to apply real-world AI assistance in the field
  • Ensure compliant, accurate sales messaging in every interaction

Who Should Attend

  • Directors, VPs, heads, C-level executives
  • Commercial excellence
  • Commercial operations
  • Sales
  • Marketing


Speakers


John Aiken, MS‑HRM, M Ed, CTMS
Sr. Director, Training & Talent Development
Veloxis Pharmaceuticals

Jennifer Troiano
Retina Account Manager
Coherus BioSciences

Kumar Erramilli
Chief Technology Officer
ACTO

Register Free: https://www.pharmexec.com/pe_w/missing-link

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Gen Li
Lynlee Brown
Related Content
Advertisement
James Van Der Beek
August 1st 2025

Guardant Partners with James Van Der Beek on Colorectal Cancer Screening Campaign

Mike Hollan
The actor was diagnosed with the disease at 46-years-old.
Jennifer Butler
August 1st 2025

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Credit: AspctStyle | stock.adobe.com. Group of pharmacists standing together and looking at the camera in a chemist. Group of healthcare professionals working in a pharmacy.
August 1st 2025

Flawless but Fake? The Ethics of AI Social Media Influencers in Pharmaceutical Advertising

Thani Jambulingam, PhD
AI influencers represent the cutting edge of digital storytelling. But when applied to pharmaceutical marketing, innovation must be balanced with integrity.
Navigating Distrust: Pharma in the Age of Social Media
August 1st 2025

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Zifo Survey Shows Biopharma Racing Toward AI Despite Data Management Challenges
August 1st 2025

Zifo Survey Shows Biopharma Racing Toward AI Despite Data Management Challenges

Don Tracy, Associate Editor
A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but highlights gaps in data integration, standardization, and infrastructure that threaten to stall progress.
Stock.adobe.com
August 1st 2025

Can AI Accelerate Clinical Review at FDA?

PharmExec Staff
With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug review and speed up approval is not here yet.
Related Content
Advertisement
James Van Der Beek
August 1st 2025

Guardant Partners with James Van Der Beek on Colorectal Cancer Screening Campaign

Mike Hollan
The actor was diagnosed with the disease at 46-years-old.
Jennifer Butler
August 1st 2025

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Credit: AspctStyle | stock.adobe.com. Group of pharmacists standing together and looking at the camera in a chemist. Group of healthcare professionals working in a pharmacy.
August 1st 2025

Flawless but Fake? The Ethics of AI Social Media Influencers in Pharmaceutical Advertising

Thani Jambulingam, PhD
AI influencers represent the cutting edge of digital storytelling. But when applied to pharmaceutical marketing, innovation must be balanced with integrity.
Navigating Distrust: Pharma in the Age of Social Media
August 1st 2025

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Zifo Survey Shows Biopharma Racing Toward AI Despite Data Management Challenges
August 1st 2025

Zifo Survey Shows Biopharma Racing Toward AI Despite Data Management Challenges

Don Tracy, Associate Editor
A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but highlights gaps in data integration, standardization, and infrastructure that threaten to stall progress.
Stock.adobe.com
August 1st 2025

Can AI Accelerate Clinical Review at FDA?

PharmExec Staff
With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug review and speed up approval is not here yet.
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.